<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Deprescribing Compass - Pharmacist Tool</title>
  <link href="https://fonts.googleapis.com/css2?family=Quicksand:wght@400;600&display=swap" rel="stylesheet">
  <style>
    body {
      font-family: 'Quicksand', sans-serif;
      background: linear-gradient(to right, #c2e9fb, #a1c4fd);
      color: #333;
      max-width: 800px;
      margin: 0 auto;
      padding: 20px;
    }
    h1 {
      color: #1e3a8a;
      text-align: center;
      font-size: 2.5rem;
      margin-bottom: 20px;
      animation: fadeInDown 1s ease-out;
    }
    @keyframes fadeInDown {
      from { opacity: 0; transform: translateY(-20px); }
      to { opacity: 1; transform: translateY(0); }
    }
    .form-section {
      background: #ffffff;
      border-radius: 20px;
      padding: 30px;
      box-shadow: 0 10px 25px rgba(0, 0, 0, 0.1);
      margin-bottom: 20px;
      animation: fadeInUp 1s ease-out;
    }
    @keyframes fadeInUp {
      from { opacity: 0; transform: translateY(20px); }
      to { opacity: 1; transform: translateY(0); }
    }
    label {
      font-weight: 600;
      display: block;
      margin-top: 15px;
    }
    textarea, select, button {
      width: 100%;
      padding: 12px;
      margin-top: 8px;
      border-radius: 8px;
      border: 1px solid #ccc;
      font-size: 1rem;
    }
    button {
      background-color: #1e3a8a;
      color: white;
      font-weight: bold;
      cursor: pointer;
      transition: background 0.3s ease;
    }
    button:hover {
      background-color: #3b82f6;
    }
    #output {
      white-space: pre-wrap;
      background-color: #f0fdf4;
      border-left: 5px solid #22c55e;
      padding: 20px;
      border-radius: 10px;
      margin-top: 20px;
      font-size: 1.1rem;
      animation: fadeIn 0.5s ease-in-out;
    }
    @keyframes fadeIn {
      from { opacity: 0; }
      to { opacity: 1; }
    }
  </style>
  <script>
    function checkDeprescribing() {
      const goals = document.getElementById("goals").value;
      const prognosis = document.getElementById("prognosis").value;
      const medications = document.getElementById("medications").value.toLowerCase().split(",").map(med => med.trim());

      let recommendations = "\u2728 Deprescribing Recommendations:\n\n";

      const classData = {
        "statin": {
          recommendation: "Statins like atorvastatin or simvastatin may be deprescribed in patients with limited life expectancy (<1 year) where primary prevention is no longer beneficial.",
          severity: "Moderate - While statins help in reducing cardiovascular risk, in end-of-life scenarios, the burden may outweigh the benefit. Continuing statins could be decreasing comfort and increasing medication burden for patients with a poor prognosis.",
          reference: "eTG, AMH",
          link: "https://www.etg.org.au/"
        },
        "acetylcholinesterase inhibitor": {
          recommendation: "Drugs like donepezil or rivastigmine may be deprescribed in end-stage dementia when no functional improvement is expected. Gradual taper is advised.",
          severity: "High - These medications may be contributing to adverse effects without meaningful benefit, impacting QOL. Discontinuing these drugs can enhance comfort by reducing confusion, sedation, and other side effects.",
          reference: "MATCH-D, AMH",
          link: "https://www.amh.net.au/"
        },
        "antiplatelet": {
          recommendation: "Agents like aspirin or clopidogrel used for primary prevention may be deprescribed if bleeding risk outweighs benefit.",
          severity: "High - Reduces bleeding risks and may be burdensome if continued in patients with limited prognosis. The continued use of antiplatelets can contribute to a higher bleeding risk, which may significantly impact patient comfort.",
          reference: "eTG, AMH",
          link: "https://www.etg.org.au/"
        },
        "biguanide": {
          recommendation: "Metformin should be reviewed in frail elderly patients, especially if eGFR <30 mL/min or low HbA1c targets.",
          severity: "Moderate - May contribute to lactic acidosis in frail patients with kidney dysfunction, decreasing overall safety. In palliative care, these medications should be reconsidered as they may pose risks without significant benefits.",
          reference: "eTG",
          link: "https://www.etg.org.au/"
        },
        "ppi": {
          recommendation: "Proton pump inhibitors like omeprazole or esomeprazole may be stepped down or ceased if indication has resolved (e.g. GORD).",
          severity: "Low - These medications should be reviewed for indications, but stopping may not significantly alter QOL. In palliative care, discontinuation may help reduce medication burden without affecting the overall comfort.",
          reference: "AMH",
          link: "https://www.amh.net.au/"
        },
        "ccb": {
          recommendation: "Calcium channel blockers like amlodipine may contribute to hypotension or falls in frail patients. Review BP targets.",
          severity: "High - Contributes to hypotension or falls in frail patients, decreasing functional ability and safety. Deprescribing these agents may prevent adverse effects such as falls and dizziness, enhancing overall patient comfort.",
          reference: "eTG",
          link: "https://www.etg.org.au/"
        },
        "insulin": {
          recommendation: "Insulin may be deprescribed or reduced in elderly/frail if HbA1c target is relaxed or risk of hypoglycaemia is high.",
          severity: "Moderate - Reducing insulin or adjusting doses in elderly patients may reduce risks of hypoglycemia and improve QOL. In palliative care, reducing insulin can help prevent unnecessary complications, improving comfort.",
          reference: "eTG, AMH",
          link: "https://www.etg.org.au/"
        },
        "anticoagulant": {
          recommendation: "Agents like warfarin or DOACs may be deprescribed in limited prognosis unless essential (e.g. mechanical valves).",
          severity: "High - May significantly impact QOL due to bleeding risks, especially in patients with limited life expectancy. Deprescribing these agents can reduce the risk of bleeding complications, improving safety and comfort.",
          reference: "AMH",
          link: "https://www.amh.net.au/"
        },
        "benzodiazepine": {
          recommendation: "Benzodiazepines may be deprescribed due to risks of falls and sedation, unless indicated for terminal agitation. Gradual taper advised.",
          severity: "High - These medications increase the risk of falls and sedation, which can significantly decrease QOL in palliative patients. Deprescribing may reduce sedation and improve mobility, enhancing the patient's comfort and independence.",
          reference: "AMH, Maudsley",
          link: "https://www.amh.net.au/ | https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/abs/benzodiazepines-in-older-people/"
        },
        "ssri": {
          recommendation: "SSRIs may be tapered and ceased if no longer beneficial, especially in palliative settings. Watch for discontinuation syndrome.",
          severity: "Moderate - Potential for discontinuation syndrome; however, stopping may improve cognitive clarity and overall QOL. Deprescribing may also help reduce sedation, improve clarity, and ease overall comfort.",
          reference: "Maudsley",
          link: "https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/abs/benzodiazepines-in-older-people/"
        },
        "bisphosphonate": {
          recommendation: "Bisphosphonates like alendronate may be stopped after 5 years or in patients near end of life with low fracture risk.",
          severity: "Low - May be unnecessary in patients near the end of life, without contributing significantly to QOL. Discontinuing bisphosphonates may reduce medication burden without compromising comfort.",
          reference: "AMH",
          link: "https://www.amh.net.au/"
        }
      };

      const classKeywords = {
        "statin": ["atorvastatin", "simvastatin", "rosuvastatin", "pravastatin"],
        "acetylcholinesterase inhibitor": ["donepezil", "rivastigmine", "galantamine"],
        "antiplatelet": ["aspirin", "clopidogrel", "dipyridamole"],
        "biguanide": ["metformin"],
        "ppi": ["omeprazole", "esomeprazole", "pantoprazole", "rabeprazole"],
        "ccb": ["amlodipine", "felodipine", "nifedipine"],
        "insulin": ["insulin glargine", "insulin aspart", "insulin detemir"],
        "anticoagulant": ["warfarin", "apixaban", "rivaroxaban", "dabigatran"],
        "benzodiazepine": ["diazepam", "temazepam", "oxazepam", "lorazepam"],
        "ssri": ["sertraline", "fluoxetine", "escitalopram", "citalopram"],
        "bisphosphonate": ["alendronate", "risedronate", "zoledronic acid"]
      };

      medications.forEach(med => {
        Object.entries(classKeywords).forEach(([drugClass, names]) => {
          if (names.some(name => med.includes(name))) {
            recommendations += `• ⚖️ ${drugClass.charAt(0).toUpperCase() + drugClass.slice(1)}: ${classData[drugClass].recommendation}\nSeverity: ${classData[drugClass].severity}\nReference: ${classData[drugClass].reference}\nLink: ${classData[drugClass].link}\n\n`;
          }
        });
      });

      if (recommendations === "\u2728 Deprescribing Recommendations:\n\n") {
        recommendations += "No specific deprescribing alerts found. Please refer to clinical judgment and local guidelines.";
      }

      document.getElementById("output").textContent = recommendations;
    }
  </script>
</head>
<body>
  <h1>Deprescribing Compass - Pharmacist Tool</h1>
  <div class="form-section">
    <label for="medications">Enter Medications (comma separated):</label>
    <textarea id="medications" rows="3"></textarea>
    <button onclick="checkDeprescribing()">Check Deprescribing</button>
  </div>
  <div id="output"></div>
</body>
</html>
